Dr Renuka Dias BMedSci, MBBS, FRCPCH, PhD

• FRCPCH: Royal College of Paediatrics and Child Health
• PhD: Genomic Medicine, Queen Mary University of London
• MBBS: University of Nottingham
• BMedSci: University of Nottingham

Dr Dias received her undergraduate training from the University of Nottingham. She was awarded her PhD in Genomic Medicine titled Epigenetics of Silver Russell Syndrome in 2012 (MRC Funded Research Training Fellowship) and received multiple awards for her PhD research. She completed her clinical training in Paediatric Endocrinology in London (Great Ormond Street Hospital, Royal London Hospital) following her PhD and became a full time NHS consultant in 2014.  

She is the Lead Paediatrician on the ELSA study and the T1DVGPLus study. She is on the Diversity in Diabetes ,SMILE-T1D, LifeArc, TREATWolfram consortium studies. She is part of the EDENT1FI consortium. She is co-chair of the Early Stage Type 1 Children and Young People’s Diabetes network. 

Dr Dias sits on research and policy committees including NIHR, Breakthrough T1D and Diabetes UK. She has also co-led several national training events in early-stage Type 1 Diabetes (including CYP National Network, Early T1D summit and YDEF early T1D meetings). 

She is a co-author on multiple national and international guidelines (ETA, NICE).

Dr Dias has been awarded grants from NIHR, Breakthrough T1D and Diabetes UK for her work in Type 1 Diabetes.

• 2nd year MBChB RED module
• MSc Genomic Medicine
• MRes/MSc course in Bioinformatics and Genomic Medicine
• Management of Childhood Diabetes course

Dr Dias is passionate about developing and supporting the next generation of researchers.

Current PhD students:
1. Saskia Dry (2026-): Early Surveillance of Type 1 Diabetes study (ELSA)
2. Simrat Kaur (2026-): Early Surveillance of Type 1 Diabetes study (ELSA)
3. Theodora Papanikalaou (2025-): Physical Activity in Early-Stage Type 1 Diabetes
(EXTEND-IT)

She also supervises Academic Clinical Lecturers and Academic Clinical Fellows.

Dr Dias’s research focusses on Type 1 Diabetes. Her work extends from screening for, and management of, early Type 1 Diabetes including preservation of beta cell function through immunotherapy trials as well as understanding and developing strategies to reduce health 
inequalities in Type 1 Diabetes.

Screening in Early Stage Type 1 Diabetes

Dr Dias is the lead Paediatrician for the ELSA study. She co-leads the Early Stage Type 1 Diabetes network.

She is a member of the EDENT1FI consortium.

Disease Modifying Therapies in Early Type 1 Diabetes

Dr Dias led the ABCD-BSPED consensus guidelines on Teplizumab for the UK and is Lead Paediatrician for the multi-centre T1DVGPlus study  

Health Inequalities

Dr Dias is passionate about reducing health inequalities in care outcomes in Type 1 Diabetes working with the NPDA to understand the gaps in care and how diabetes care for young people needs to evolve with advances in therapies. 

Renuka’s clinical interests align with her research interests, and she

• is the Lead for Paediatric Diabetes at BCH and for the Nationally commissioned Wolfram Syndrome service based in Birmingham
• is Programme Organising Committee Chair for British Society of Paediatric Endocrinology
• sits on DRSG7 committee (Diabetes UK)
• is also medical advisor for AMEND, Wolfram Syndrome UK.